1.1M Android Apps Tracked Updated 2 min ago Revenue Forecasts
Create Account Sign In
Home

CellaVision CellAtlas

58
Quality Score
Solid

CellaVision CellAtlas

Medium confidence
4.4 ✍️ Editor
✍️ bumetric analysis

CellaVision CellAtlas is an Android app from CellaVision in the Medical category, currently rated 4.4★ across 655 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.

Quality Score is 58: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

💰 Monthly revenue · now vs forecast
● Right now
$500
per month
12-mo forecast
$437 – $1575
per month
24-mo forecast
$405 – $3644
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
  • Title & subtitle keyword fit
  • Description hook & conversion structure
  • Screenshots, ratings, reviews strategy
Run free AI audit →
Typical impact: +2-5× organic installs
🔔Notify me when this app's revenue changes by

📊 Performance Tracking LIVE

Loading…
idle
0%
Rating
Reviews
Forecast Revenue / mo
Snapshots tracked
0
since first record
ONE-TIME · BUILD💰 Estimated build cost
$120K
What it cost to build · not monthly revenue
Likely range $90K – $160K
$25K · MVP floor$100K · indie scale$500K+ · studio build
📈Slow ROI — current MRR is well below build cost

Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.

Where the money goes
🧱MVP baseline (design + 1-store ship)+$28K
📱5 unique screens × $4.5K+$22K
Medical complexity ×1.55+$27K
🌐Cross-platform reach (iOS + Android)+$43K
Total estimate$120K
👥 Estimated audience size
36K
Lifetime downloads (US-equivalent)
Monthly active
9.0K
Daily active
1.8K

Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.

How we sized it
📲Medical engagement~55 installs / rating
🔁Medical D30 retention25%
📍DAU / MAU stickiness0.20
DAU / MAU20% sticky
🔬

How we forecast this revenue

LOW CONFIDENCE
Baseline
$500/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
6 months
$426 – $993
12 months
$437 – $1.6K
24 months
$405 – $3.6K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊

BU Investment Matrix

Pre-traction · 40/100INDIE TIERlimited signal
RevenueQualityMarketGrowthMoatSafetyFounderMonetiz.
Revenue Strength
2.7
Product Quality
6.1
Market Position
0.0
Growth Velocity
5.0
Defensibility
4.3
Operational Safety
9.0
Founder Strength
3.6
Monetization Maturity
1.0
  • 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
  • ⭐ Quality: 4.37★ across 655 reviews — solid.
  • 📍 Market: Not yet charting in any of the 9 monitored markets.
  • 📈 Growth: last update 206d ago — slow cadence.
  • ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $9K-$16K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:

💰 Forecast Revenue / mo

MODEL
Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 4 of 4 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
Mature app (9y old)METRIC
+$1,500
Good rating (4.4★)METRIC
+$800
Ad-supported / freemiumMETRIC
+$600
Early-stage install base (655 ratings)METRIC
+$400
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📈 Reviews Growth

LIVE
Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE
Average rating evolution. Updates with each new review batch.

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name
CellaVision CellAtlas
Developer
CellaVision
Bundle ID
se.cellavision.cellatlas
App Store URL
Open in App Store
Category
Medical
Content rating
Not found
Languages
Not found

Company

Website
cellavision.com
Tagline
Not found
Description
Not found
Founded
Not found
HQ / Address
Not found
Employees
Not found
Logo
Not found

Revenue

Verified revenue / mo
Not found
AI revenue estimate / mo
Not found
AI annual estimate
Not found
ML model estimate / mo
$392/mo
Top-grossing rank
Not found
All-time revenue
Not found
Pricing
Not found

Founder

Founder data not yet collected for this app.

Funding

Funding data not yet collected for this app.

Press & Links

Press & Links data not yet collected for this app.

Contacts & Socials

Contacts & Socials data not yet collected for this app.
AI Revenue EstimateCONFIDENCE: HIGH
The Android app "CellaVision CellAtlas" by CellaVision appears to be a free educational and reference tool for blood cell morphology, intended for laboratory personnel and students. Public sources, including app store descriptions, do not indicate any direct revenue generation through subscriptions or in-app purchases for the mobile application. The app serves as a supplementary tool to promote CellaVision's primary business of selling digital microscopy solutions and systems to laboratories.
Sources mentioned: Sensor Tower, Statista, Adapty, Reddit, founder claims, app review databases, Google Play, App Store
📈Ratings growth655 ratings+34% lifetimeShow 3-year history estimate ▾Jun 2023Dec 2024May 2026
Tracked (1 weeks) Pre-tracking estimate (36 weeks) · model-based, ±5% noise · anchored to release date and current value
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

📝 About this app

CellAtlas is developed by CellaVision in close partnership with morphology experts from around the world. It combines a series of mini lectures with an extensive cell image library – giving students and laboratory professionals a top-line introduction to cell morphology. The game CellQuiz is a fun way to test your knowledge in cell morphology.
App Specs
🔐 Own this app? Claim & verify MRR →
🔖 v4.1.13🔄 updated 0d ago📂 Medical💰 Free
🧪

Tech & Domain Intel — cellavision.com

Mail provider
Microsoft 365
Tech stack
SendGrid · Microsoft 365
Derived from public RDAP + DNS TXT records (no scraping, no login).
🔔

Track this app’s revenue

FREE
Get an email when revenue moves by your threshold. No spam, unsubscribe in one click.

📝 Description

95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for CellaVision CellAtlas: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
Read deep-dive →

Similar apps in Medical

About this analysis
ZCAnalyzed by Zakhar Chumak · founder, bumetric·Full methodology·Medium confidence

Why medium confidence: 655 ratings · no founder-verified revenue (model estimate only).

Frequently Asked Questions

4 answers · auto-generated from this app's public data
How much does CellaVision CellAtlas make per month?
Based on our ML-calibrated revenue forecast, CellaVision CellAtlas earns approximately $391/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like CellaVision CellAtlas?
Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes CellaVision CellAtlas?
CellaVision CellAtlas is published by CellaVision on the Google Play Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is CellaVision CellAtlas's BU Score?
CellaVision CellAtlas has a BU Score of 58/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.